Adial Pharmaceuticals's total assets for Q3 2024 were $6.71M, an increase of 35.65% from the previous quarter. ADIL total liabilities were $829.05K for the fiscal quarter, a 23.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.